State of Wyoming Makes New Investment in Sotera Health Company $SHC

State of Wyoming purchased a new stake in Sotera Health Company (NASDAQ:SHC) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 56,651 shares of the company’s stock, valued at approximately $1,006,000.

A number of other large investors also recently made changes to their positions in SHC. IFP Advisors Inc grew its position in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new position in Sotera Health in the fourth quarter valued at $27,000. Root Financial Partners LLC lifted its position in Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the period. EverSource Wealth Advisors LLC lifted its position in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the period. Finally, Eurizon Capital SGR S.p.A. purchased a new position in Sotera Health during the fourth quarter worth about $40,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

SHC has been the subject of several recent analyst reports. UBS Group set a $19.00 price target on Sotera Health in a report on Wednesday, June 24th. Barclays increased their price objective on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Piper Sandler restated an “overweight” rating and issued a $25.00 target price (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Finally, Citigroup upped their price target on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus price target of $21.50.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $18.89 on Friday. The business’s fifty day moving average price is $17.49 and its 200 day moving average price is $16.34. Sotera Health Company has a twelve month low of $13.09 and a twelve month high of $19.85. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. The stock has a market capitalization of $5.39 billion, a P/E ratio of 33.14 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, research analysts anticipate that Sotera Health Company will post 0.87 earnings per share for the current year.

Insider Activity

In other news, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares in the company, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.